eClinical Tech News

ZyVersa Therapeutics announced new research supporting the potential of its Inflammasome ASC Inhibitor IC 100 as a disease-modifying treatment...

Galimedix Therapeutics announced published preclinical data on GAL-201, a small molecule drug candidate for Alzheimer’s disease. The data demonstrates...

Tango Therapeutics has initiated a Phase 1/2 clinical trial of TNG456, a brain-penetrant PRMT5 inhibitor, for patients with MTAP-deleted...

Tonix Pharmaceuticals has initiated a Phase 2 trial, called OASIS, to evaluate TNX-102 SL for reducing the severity of...

23andMe, a consumer genetics and biotechnology company, has entered into a definitive agreement to be acquired by Regeneron Pharmaceuticals...

EXACT Therapeutics announced positive final data from its Phase 1 ACTIVATE trial, demonstrating that Acoustic Cluster Therapy (ACT) significantly...

CRISPR Therapeutics and Sirius Therapeutics have partnered to develop and commercialize SRSD107, a long-acting siRNA therapy for thromboembolic disorders....

BridgeBio Pharma released data from its Phase 3 ATTRibute-CM trial of acoramidis, showing a link between early, sustained increases...

Kymera Therapeutics announced preclinical data for KT-621, an oral STAT6 degrader, showing its potential as a once-daily treatment for...

The Coalition to Transform Clinical Trial Engagement (CTCTE) launched the Champions for Change – Paid Time Off (PTO) Initiative...